Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070276
Filing Date
2025-05-13
Accepted
2025-05-13 16:00:26
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20250331.htm   iXBRL 10-Q 1447684
2 EX-31.1 meip-ex31_1.htm EX-31.1 17037
3 EX-32.1 meip-ex32_1.htm EX-32.1 7400
4 GRAPHIC img105904496_0.jpg GRAPHIC 132946
  Complete submission text file 0000950170-25-070276.txt   6550978

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20250331.xsd EX-101.SCH 1117108
70 EXTRACTED XBRL INSTANCE DOCUMENT meip-20250331_htm.xml XML 870901
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41827 | Film No.: 25939774
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)